[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2012097034A5 - - Google Patents

Download PDF

Info

Publication number
JP2012097034A5
JP2012097034A5 JP2010246112A JP2010246112A JP2012097034A5 JP 2012097034 A5 JP2012097034 A5 JP 2012097034A5 JP 2010246112 A JP2010246112 A JP 2010246112A JP 2010246112 A JP2010246112 A JP 2010246112A JP 2012097034 A5 JP2012097034 A5 JP 2012097034A5
Authority
JP
Japan
Prior art keywords
composition
hipokisanchi
autoinducer
creatine
taurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010246112A
Other languages
Japanese (ja)
Other versions
JP2012097034A (en
JP5756614B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2010246112A priority Critical patent/JP5756614B2/en
Priority claimed from JP2010246112A external-priority patent/JP5756614B2/en
Publication of JP2012097034A publication Critical patent/JP2012097034A/en
Publication of JP2012097034A5 publication Critical patent/JP2012097034A5/ja
Application granted granted Critical
Publication of JP5756614B2 publication Critical patent/JP5756614B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (3)

クレアチン、タウリン、フルクトース−6−リン酸及びヒポキサンチン、並びにこれらの塩からなる群より選ばれる少なくとも1種を有効成分とするオートインデューサー−2阻害剤。 Creatine, taurine, fructose-6-phosphate and Hipokisanchi emissions, as well as autoinducer-2 inhibitor comprising as an active ingredient, at least one selected from the group consisting of salts. クレアチン、タウリン、フルクトース−6−リン酸及びヒポキサンチン、並びにこれらの塩からなる群より選ばれる少なくとも1種を有効成分とする齲蝕病の予防及び/又は治療剤。 Creatine, taurine, fructose-6-phosphate and Hipokisanchi down, and the prevention and / or therapeutic agent for dental caries disease comprising as an active ingredient, at least one selected from the group consisting of salts. 請求項1記載のオートインデューサー−2阻害剤を含有してなる、医薬組成物、食品組成物、口腔用組成物又は化粧料組成物。   A pharmaceutical composition, food composition, oral composition or cosmetic composition comprising the autoinducer-2 inhibitor according to claim 1.
JP2010246112A 2010-11-02 2010-11-02 Autoinducer-2 inhibitor and preventive and / or therapeutic agent for caries disease Active JP5756614B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010246112A JP5756614B2 (en) 2010-11-02 2010-11-02 Autoinducer-2 inhibitor and preventive and / or therapeutic agent for caries disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010246112A JP5756614B2 (en) 2010-11-02 2010-11-02 Autoinducer-2 inhibitor and preventive and / or therapeutic agent for caries disease

Publications (3)

Publication Number Publication Date
JP2012097034A JP2012097034A (en) 2012-05-24
JP2012097034A5 true JP2012097034A5 (en) 2013-10-31
JP5756614B2 JP5756614B2 (en) 2015-07-29

Family

ID=46389377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010246112A Active JP5756614B2 (en) 2010-11-02 2010-11-02 Autoinducer-2 inhibitor and preventive and / or therapeutic agent for caries disease

Country Status (1)

Country Link
JP (1) JP5756614B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2593618T3 (en) * 2012-12-18 2016-12-12 Sunstar Suisse Sa Topical oral composition to relieve the symptoms of dry mouth and for the treatment of canker sores
WO2017127025A1 (en) * 2016-01-19 2017-07-27 Namz Pte. Ltd. A cosmetic composition and the use thereof for regulating skin quality
CN108042384B (en) * 2018-01-08 2020-07-10 弘美制药(中国)有限公司 A composition with oral cleaning and treating effects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1100488E (en) * 1998-07-28 2003-09-30 Synthes Ag USE OF CREATINE COMPOUNDS FOR TREATMENT OF BONE AND CARTILAGE CELLS AND TISSUES
DE19841385A1 (en) * 1998-09-10 2000-03-16 Sueddeutsche Kalkstickstoff Use of creatine and/or creatine derivatives as moisturizers in cosmetic compositions
JP2010159219A (en) * 2009-01-07 2010-07-22 Kao Corp Ai-2 inhibitor

Similar Documents

Publication Publication Date Title
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
CY1118813T1 (en) PHARMACEUTICAL COMPOSITIONS OF TRAMADOL AND COXYL-CYLINDERS
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
AR080491A1 (en) ORAL FORMULATIONS AND LIPOFILIC SALTS OF METHYLNTREXONE
JP2015523407A5 (en)
IL223783B (en) Substituted 1-indole compound for use in the treatment of a disease or condition, a pharmaceutical composition comprising the compound and use of the compound for the preparation of a medicament
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
EA200901423A1 (en) BENZIMIDAZOLY AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
JP2015038135A5 (en)
JP2007238598A5 (en)
BRPI0814666A2 (en) pharmaceutical composition for oral administration, use of a formulation. process for preparing a solid dosage form, and, solid dosage form
BRPI1009392A2 (en) "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
BR112012003280A2 (en) pharmaceutical composition for oral administration, method for treating a disease, use of the compound, and, compound.
WO2011056240A3 (en) Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
PT2459153E (en) Pharmaceutical or cosmetic or dietetic composition for promoting a hair pigmentation effect
JP2012508256A5 (en)
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
JP2012097034A5 (en)
ATE460934T1 (en) PHARMACEUTICAL PREPARATIONS OF CIPROFLOXACIN
JP2012097036A5 (en)
MX2013005482A (en) Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria.
JP2013032308A5 (en)
CY1111361T1 (en) NEW DESIGNS RAR RECEPTORS ASSOCIATES, USE IN HUMAN MEDICAL AND IN COSMETOLOGY
RU2011143735A (en) MEANS FOR SKIN WHITENING AND COSMETIC METHOD FOR WHITENING SKIN